NCT00553969
Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease
See it on ClinicalTrials.gov ↗91 people
28.6%
71.4%
26 womenmiddle line = equal numbers65 men
- Phase
- PHASE1, PHASE2
- Paid for by
- University of Minnesota
- Finished
- 2010-12
- Health conditions
- Pre-hypertension
- Who could join
- Anyone
- Ages
- 19 Years – no maximum
- Average age
- mean 52.25 years
- Age 65+
- 0%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No pregnant women
Women who were pregnant could not join.
“…ance to beta blockers or ACE inhibitors, angiotensin receptor blocker therapy, or diabetes. Pregnant or lactating women, and women of child-bearing age who are not using an acceptable form of contraception are also excluded from this study.”
- No breastfeeding moms
Women who were breastfeeding could not join.
“…ance to beta blockers or ACE inhibitors, angiotensin receptor blocker therapy, or diabetes. Pregnant or lactating women, and women of child-bearing age who are not using an acceptable form of contraception are also excluded from this study.”
- Had to use birth control
Women who couldn't or didn't want to use birth control were turned away.
“…ance to beta blockers or ACE inhibitors, angiotensin receptor blocker therapy, or diabetes. Pregnant or lactating women, and women of child-bearing age who are not using an acceptable form of contraception are also excluded from this study.”
- Weight limit (BMI)
Women with a higher (or lower) body weight were turned away.
“Body mass index ≥ 30”
- No diabetes
Women with diabetes were turned away.
“…ance to beta blockers or ACE inhibitors, angiotensin receptor blocker therapy, or diabetes. Pregnant or lactating women, and women of child-bearing age who are not using an acceptable form of contraception are also excluded from this study.”
Study titles and rules are shown in their original English.